VENUS REMEDIES
|
The Current P/S Ratio of VENUS REMEDIES is 2.68.
| Share Price | ₹1,625.2 | Aug 28,2026 |
| Market Cap | ₹2,177.7 Cr | |
| Sales-TTM | ₹811.3 Cr | TTM-Consolidated Results |
| Price/Sales | 2.68x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,177.7 Cr] as on Aug 28,2026
(/) Sales [ ₹811.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.68x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay '2.68 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !
The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.
Historical PS (Price/Sales) ratio chart of VENUS REMEDIES
PS Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 0.75x.
- VENUS REMEDIES 's operated at median p/e ratio of 0.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2026 at 1.43x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2023 of 0.39x.
How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VENUS REMEDIES | 811.3 | 2.68 | 2,177.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.69 | 460,696.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.91 | 246,063.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.18 | 191,515.0 |
| CIPLA LTD | 28,324.4 | 4.04 | 114,554.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.96 | 98,308.6 |
| MANKIND PHARMA LTD | 14,737.9 | 6.69 | 98,598.7 |
| LUPIN LTD | 29,966.6 | 3.32 | 99,455.3 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.14 | 118,404.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.72 | 94,937.4 |
| LAURUS LABS LTD | 7,269.6 | 14.38 | 104,567.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.68x |
| Max industry PS | 21.91x |
| Median industry PS | 4.14x |
| Average industry PS | 7.52x |
You may also like the below Video Courses